Thermo Fisher reports $11.99B Q2 2026 sales
Thermo Fisher Scientific's revenues climbed 10% to $11.99 billion in the second quarter of 2026, driven by end market strength and innovation, while reporting 13% adjusted EPS growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day